Prevalence of Chronic Diabetic Complications in Newly Diagnosed versus Known Type 2 Diabetic Subjects in a Sample of Alexandria Population, Egypt

被引:20
|
作者
Khalil, Samir Assaad [1 ]
Megallaa, Magdy Helmy [1 ]
Rohoma, Kamel Hemida [1 ]
Guindy, Myriam AbouSeif [2 ]
Zaki, Adel [3 ]
Hassanein, Mohamed [4 ,5 ]
Malaty, Amin Helmy [6 ]
Ismael, Hanaa Mohamed [7 ]
Kharboush, Ibrahim Fahmy [8 ]
El Kafash, Dalal Nasr-Eldein [2 ]
Sallam, Hassan Nooman [9 ]
Desouky, Iman Abdelkareem [6 ]
机构
[1] Alexandria Univ, Fac Med, Dept Internal Med, Unit Diabet & Metab, Alexandria, Egypt
[2] Alexandria Univ, Fac Med, Dept Clin Pathol, Alexandria, Egypt
[3] Alexandria Univ, Med Res Inst, Dept Biostat, Alexandria, Egypt
[4] Dubai Hlth Author, Dubai Hosp, Dubai, U Arab Emirates
[5] Cardiff Univ, Cardiff, S Glam, Wales
[6] Alexandria Univ, Fac Med, Dept Ophthalmol, Alexandria, Egypt
[7] Alexandria Univ, High Inst Publ Hlth, Dept Nutr, Alexandria, Egypt
[8] Alexandria Univ, High Inst Publ Hlth, Dept Maternal & Child Hlth, Alexandria, Egypt
[9] Alexandria Reg Ctr Womens Hlth & Dev, Alexandria, Egypt
关键词
Prevalence; diabetic complications; Alexandria; Egypt; chronic; hyperglycemia; MICROVASCULAR COMPLICATIONS; GLUCOSE CONTROL; RISK-FACTORS; FOLLOW-UP; RETINOPATHY; MELLITUS; DISEASE; CARE; ASSOCIATION; MANAGEMENT;
D O I
10.2174/1573399814666180125100917
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In Egypt, data on the prevalence of chronic diabetic complications, which are essential for the adjustment of policies and practices related to diabetes care, are scarce. Therefore, the aim of this study was to determine the frequency of chronic complications of diabetes; namely neuropathy, Diabetic Kidney Disease (DKD), retinopathy and Peripheral Arterial Disease (PAD) in newly-diagnosed versus known type 2 diabetic patients. Subjects & Methods: This is a cross-sectional study that is based on a previous household survey conducted on a representative sample of the population of Alexandria, Egypt. This study included 506 consecutive subjects with type 2 diabetes; 323 patients with previously known T2DM and 183 patients with newly diagnosed T2DM (discovered during the survey). For each participant, a focused history was taken. Comprehensive clinical examination was done including fundus examination, foot examination and assessment of ankle brachial index. Laboratory tests included HbAlc, lipids profile, serum creatinine and Urinary Albumin Creatinine Ratio (UACR). Results: Peripheral neuropathy was detected in 20% of the studied patients; 29.4% of known patients and 3.3% of newly diagnosed patients (p<0.001). Diabetic kidney disease was detected in 33.2% of the studied patients; 46.1% of known patients and 10.4% of newly diagnosed patients (p<0.001). Diabetic retinopathy was detected in 34.6% of the studied patients; 48.3% of known patients and 10.4% of newly diagnosed patients (p<0.001). Peripheral arterial disease was detected in 32.6% of the studied patients; 45.5% of known patients and 9.8% of newly diagnosed patients (p<0.001). In patients with known diabetes, the presence of any of the studied complications (neuropathy, diabetic kidney disease, retinopathy or PAD) was significantly associated with the presence of all other complications (p<0.001). In patients with newly-diagnosed diabetes, the presence of diabetic kidney disease was significantly associated with the presence of retinopathy (p<0.001), with no significant association with PAD (p=0.357). Conclusion: The present study confirms that a considerable proportion of people with T2DM have microvascular complications and/or PAD at the time of, and possibly years before, diagnosis. Having shown that, it is strongly recommended to apply appropriate screening strategies for subjects with diabetes at the time of diagnosis. Finally, these results should be considered as a call for action for the health care planners and providers in our region to plan for early screening for diabetes and its complications to reduce the disease burden in our community.
引用
收藏
页码:74 / 83
页数:10
相关论文
共 50 条
  • [21] Effects of a fixed-dose combination of sitagliptin and metformin versus respective monotherapies in newly diagnosed type 2 diabetic subjects
    Bhosle, Deepak S.
    Bhagat, Abhijeet H.
    Patil, Anant D.
    Bobde, Jyoti A.
    Bhagat, Amrapali A.
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2017, 37 (01) : 16 - 20
  • [22] Lipoprotein(a) in type 2 diabetic subjects and its relationship to diabetic microvascular complications
    Chandni, Radhakrishnan
    Ramamoorthy, Kollengode Parameswaran
    WORLD JOURNAL OF DIABETES, 2012, 3 (05): : 105 - 109
  • [23] Serum Albumin, but not Bilirubin, is Associated with Diabetic Chronic Vascular Complications in a Chinese Type 2 Diabetic Population
    Zhu, Yu
    Cai, Xiaoling
    Liu, Yan
    Hu, Mengdie
    Zhou, Lingli
    Liu, Wei
    Wu, Jing
    Zhang, Rui
    Gao, Xueying
    Yang, Wenjia
    Zhang, Simin
    Gong, Siqian
    Luo, Yingying
    Li, Meng
    Gao, Leili
    Chen, Ling
    Chen, Jing
    Huang, Xiuting
    Ren, Qian
    Zhang, Xiuying
    Zhou, Xianghai
    Han, Xueyao
    Ji, Linong
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [24] Serum Albumin, but not Bilirubin, is Associated with Diabetic Chronic Vascular Complications in a Chinese Type 2 Diabetic Population
    Yu Zhu
    Xiaoling Cai
    Yan Liu
    Mengdie Hu
    Lingli Zhou
    Wei Liu
    Jing Wu
    Rui Zhang
    Xueying Gao
    Wenjia Yang
    Simin Zhang
    Siqian Gong
    Yingying Luo
    Meng Li
    Leili Gao
    Ling Chen
    Jing Chen
    Xiuting Huang
    Qian Ren
    Xiuying Zhang
    Xianghai Zhou
    Xueyao Han
    Linong Ji
    Scientific Reports, 9
  • [25] Lens fluorescence in newly diagnosed type 2 diabetic patients
    Kessel, L
    Larsen, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U257 - U257
  • [26] Prevalence of thyroid dysfunction in newly diagnosed type 1 diabetic Iranian children
    Monajemzadeh, Seyed Mehdi
    HORMONE RESEARCH, 2009, 72 : 308 - 308
  • [27] Increased prevalence of proteinuria in diabetic sibs of proteinuric type 2 diabetic subjects
    Fava, S
    Azzopardi, J
    Hattersley, AT
    Watkins, PJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (04) : 708 - 712
  • [28] INCIDENCE OF TUBERCULOSIS AND PNEUMONIA IN A NEWLY DIAGNOSED TYPE 2 DIABETIC POPULATION AND THE IMPACT OF RAS THERAPY
    Soto, M.
    Bang, S., I
    McCombs, J.
    Rodgers, K.
    VALUE IN HEALTH, 2017, 20 (05) : A166 - A166
  • [29] Metformin improves oxidative stress and decreases platelet activation in newly diagnosed type 2 diabetic subjects
    Formoso, G.
    De Filippis, E. A.
    Michetti, N.
    Ciabattoni, G.
    Di Fulvio, P.
    Pandolfi, A.
    Capani, F.
    Davl, G.
    Consoli, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 353 - 353
  • [30] Effective renal plasma flow and filtration fraction in nondiabetic and newly diagnosed type 2 diabetic subjects
    Ollerton, RL
    Playle, RA
    Luzio, SD
    Evans, WD
    Burch, A
    Owens, DR
    DIABETOLOGIA, 1999, 42 : A270 - A270